Market Tracker

04/29 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

120.87
Delayed Data
As of 3:59pm ET
 -2.25 / -1.83%
Today’s Change
71.63
Today|||52-Week Range
131.84
+11.48%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close123.12
Today’s open123.14
Day’s range119.29 - 123.65
Volume419,799
Average volume (3 months)425,685
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+1.78%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio10.0
Price/Sales32.00
Price/Book8.07

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.82-2.40%
MDCOMedicines Co-0.24-0.67%
MYGNMyriad Genetics Inc-1.15-3.10%
HZNPHorizon Pharma PLC-0.13-0.84%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 4, 2016
EPS forecast (this quarter)$0.65
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts